Literature DB >> 11238555

How much help does a vaccine-induced T-cell response need?

J S Weber1, J J Mulé.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11238555      PMCID： PMC199430          DOI： 10.1172/JCI12403

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  19 in total

1.  Long-term survival of anti-tumor lymphocytes generated by vaccination of patients with melanoma with a peptide vaccine.

Authors:  J H Stewart; S A Rosenberg
Journal:  J Immunother       Date:  2000 Jul-Aug       Impact factor: 4.456

2.  Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo.

Authors:  E Jäger; M Ringhoffer; H P Dienes; M Arand; J Karbach; D Jäger; C Ilsemann; M Hagedorn; F Oesch; A Knuth
Journal:  Int J Cancer       Date:  1996-07-03       Impact factor: 7.396

3.  Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine.

Authors:  J M Timmerman; R Levy
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

4.  Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents.

Authors:  K A Candido; K Shimizu; J C McLaughlin; R Kunkel; J A Fuller; B G Redman; E K Thomas; B J Nickoloff; J J Mulé
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

5.  Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation.

Authors:  E M Jaffee; R H Hruban; B Biedrzycki; D Laheru; K Schepers; P R Sauter; M Goemann; J Coleman; L Grochow; R C Donehower; K D Lillemoe; S O'Reilly; R A Abrams; D M Pardoll; J L Cameron; C J Yeo
Journal:  J Clin Oncol       Date:  2001-01-01       Impact factor: 44.544

6.  Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients.

Authors:  K L Knutson; K Schiffman; M L Disis
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

7.  Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes.

Authors:  M V Dhodapkar; J Krasovsky; R M Steinman; N Bhardwaj
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

8.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

9.  Human HER-2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for 'self' tumour antigens.

Authors:  M L Disis; F M Shiota; M A Cheever
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

10.  Decreased antigen presentation by dendritic cells in patients with breast cancer.

Authors:  D I Gabrilovich; J Corak; I F Ciernik; D Kavanaugh; D P Carbone
Journal:  Clin Cancer Res       Date:  1997-03       Impact factor: 12.531
View more
  1 in total

1.  Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cancer patients.

Authors:  Michael M Woll; Christine M Fisher; Gayle B Ryan; Jennifer M Gurney; Catherine E Storrer; Constantin G Ioannides; Craig D Shriver; Judd W Moul; David G McLeod; Sathibalan Ponniah; George E Peoples
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.